Expression of concern
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Paper Information
Record ID:
34204
Author(s):
Journal:
Publication Date:
August 14, 2020
Retraction Date:
October 11, 2021
(4.1 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
- Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Ain-Shams University, Cairo, Egypt
- Public Health and Community Medicine, Menoufia University, Menoufia, Egypt
- Department of Forensic Medicine and Toxicology, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Al-Azhar University, Cairo, Egypt
Country:
🇪🇬 EgyptArticle Type:
Publisher:
American Society of Tropical Medicine and Hygiene
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.4269/ajtmh.20-0873Citations (137)
137
Total Citations45
Post-Retraction(32.8%)
92
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
28
Within 1 year
4
After 2+ years
1294
Days since retraction (latest)
Hydroxychloroquine use during the first COVID-19 wave: a case study highlighting the urgent need to enhance research practices within the publication ecosystem
Charlotte Beaudart, Flora T. Musuamba, Médéa Locquet et al. (5 authors)
Archives of Public Health
Open Access
Published: Apr 2025
1294 days after retraction
Concerns about data integrity of randomized clinical trials from one author in the European Journal of Gastroenterology & Hepatology
Kelly X. Zhou, Gideon Meyerowitz‐Katz, Tim Skern et al. (4 authors)
European Journal of Gastroenterology & Hepatology
Published: Mar 2025
1262 days after retraction
EFICÁCIA DA CLOROQUINA E HIDROXICLOROQUINA NA PROFILAXIA E TERAPIA DA COVID-19 - UMA REVISÃO SISTEMÁTICA
Beatriz de Faria Chaimowicz, Ana Carolina Wegmann Villela, Bruno Petrocchi Vieira de Menezes et al. (10 authors)
Revista Foco
Open Access
Published: Jul 2024
1022 days after retraction
Impact of COVID-19 Medication (Favipiravir and Hydroxychloroquine) on High Frequency Hearing
Sandhra Sakariyas, Gish Chacko, N.A. Vikas et al. (4 authors)
Indian Journal of Otolaryngology and Head & Neck Surgery
Published: Nov 2023
757 days after retraction
“COVID KIT” AND ITS CLINICAL MANIFESTATIONS: A SYSTEMATIC REVIEW
Bruna da Silva Teixeira, Síndel de Oliveira Morais, Ana Gabriela Macedo da Silva Zanardo
International Journal of Health Science
Open Access
Published: Sep 2023
708 days after retraction
A linked physiologically based pharmacokinetic model for hydroxychloroquine and metabolite desethylhydroxychloroquine in SARS‐CoV‐2(−)/(+) populations
Claire Steinbronn, Yashpal S. Chhonker, Jenell Stewart et al. (17 authors)
Clinical and Translational Science
Open Access
Published: Apr 2023
3 citations
3 citations
565 days after retraction
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla et al. (5 authors)
European Journal of Clinical Pharmacology
Open Access
Published: Apr 2023
19 citations
19 citations
556 days after retraction
Monotherapy versus polytherapy of enoxaparin and hydroxychloroquine for the treatment of COVID-19: A randomized controlled clinical trial
Amira S. A. Said, Raghda R. S. Hussein, Doaa Mahmoud Khalil et al. (6 authors)
Pharmacy Practice
Open Access
Published: Apr 2023
3 citations
3 citations
541 days after retraction
Coronaviruses, Lysosomes, and Secondary Bacterial Infections: Coronaviruses Outsmart the Host
Xiaohua Peng, Charles S. Dela Cruz, Lokesh Sharma
DNA and Cell Biology
Published: Feb 2023
3 citations
3 citations
487 days after retraction
A REVIEW ON OMICRON (VOC) PREVENTION, GLOBAL RISK ASSESSMENT AND EFFECTIVENESS OF COVID-19 VACCINES AGAINST OMICRON
Kumar Gaurav, Ravi Kumar, Ramesh Chaudhary et al. (4 authors)
Deleted Journal
Open Access
Published: Feb 2023
480 days after retraction
Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
Felipe Eduardo Valencise, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
International Journal of Environmental Research and Public Health
Open Access
Published: Jan 2023
8 citations
8 citations
465 days after retraction
Clinical trials and future perspectives of antiinflammatory agents
Kamini, Anoop Kumar, Pooja A. Chawla et al. (4 authors)
Elsevier eBooks
Published: Jan 2023
447 days after retraction
COVID‐19: Inpatient Management
Angelena Lopez, Yuri Matusov, Isabel Pedraza et al. (6 authors)
Unknown Journal
Published: Dec 2022
445 days after retraction
The response to the COVID-19 pandemic: With hindsight what lessons can we learn?
Mark A. Faghy, Ross Arena, Andrew P. Hills et al. (10 authors)
Progress in Cardiovascular Diseases
Open Access
Published: Dec 2022
8 citations
8 citations
421 days after retraction
FEATURES OF PATHOGENESIS, COURSE AND THERAPY OF PNEUMONIA UNDER COVID-19 (Literature Review)
V.M. Zhdan, М. Yu. Babanina, Kh.R. Boriak et al. (5 authors)
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії
Open Access
Published: Nov 2022
3 citations
3 citations
414 days after retraction
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir
Bandar Alosaimi, Huda M. Alshanbari, Muath Alturaiqy et al. (13 authors)
Pharmaceuticals
Open Access
Published: Nov 2022
409 days after retraction
A systematic review of acute and emergency care interventions for adolescents and adults with severe acute respiratory infections including COVID-19 in low- and middle-income countries
Stephanie Chow Garbern, Pryanka Relan, Gerard O’Reilly et al. (8 authors)
Journal of Global Health
Open Access
Published: Nov 2022
8 citations
8 citations
392 days after retraction
Re: Remdesivir for the treatment of COVID-19 by Lee et al.
Alessia Beccacece, Tommaso Ascoli Bartoli, Emanuele Nicastri
Clinical Microbiology and Infection
Open Access
Published: Oct 2022
358 days after retraction
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram et al. (28 authors)
PLoS ONE
Open Access
Published: Sep 2022
9 citations
9 citations
353 days after retraction
Identification of Suitable Drug Combinations for Treating COVID-19 Using a Novel Machine Learning Approach: The RAIN Method
Aliakbar Kiaei, Nader Salari, Mahnaz Boush et al. (7 authors)
Life
Open Access
Published: Sep 2022
12 citations
12 citations
343 days after retraction
Zinc and COVID-19: Immunity, Susceptibility, Severity and Intervention
Fan Wang, Jiayi Zhong, Rui Zhang et al. (7 authors)
Critical Reviews in Food Science and Nutrition
Published: Sep 2022
6 citations
6 citations
336 days after retraction
Antiporphyrics, antithrombotics and erythropoiesis stimulating agents to treat Covid-19: A living systematic review and meta-analysis
Lianne Abrahams
Unknown Journal
Open Access
Published: Sep 2022
1 citation
1 citation
331 days after retraction
COVID-19 experiences and vaccine confidence among health workers and non-health workers
Beckie N. Tagbo, Adaobi Bisi-Onyemaechi, Chinedu Chukwubike et al. (4 authors)
Nigerian Journal of Medicine
Open Access
Published: Sep 2022
325 days after retraction
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics
Denise Battaglini, Fernanda F. Cruz, Chiara Robba et al. (5 authors)
Expert Opinion on Investigational Drugs
Published: Sep 2022
6 citations
6 citations
325 days after retraction
Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone
Bashir Lawal, Yu-Cheng Kuo, Maryam Rachmawati Sumitra et al. (5 authors)
Computers in Biology and Medicine
Open Access
Published: Jul 2022
9 citations
9 citations
273 days after retraction
Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of Randomized Controlled Trials Published on COVID-19
Athira S Joshy, Christy Thomas, Saphal Surendran et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2022
1 citation
1 citation
187 days after retraction
Efficacy of pharmacological interventions in COVID‐19: A network meta‐analysis
Sandhiya Selvarajan, Annuja Anandaradje, Santhosh Shivabasappa et al. (6 authors)
British Journal of Clinical Pharmacology
Open Access
Published: Mar 2022
9 citations
9 citations
171 days after retraction
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
Álvaro Avezum, Gustavo B.F. Oliveira, Haliton Alves de Oliveira et al. (40 authors)
The Lancet Regional Health - Americas
Open Access
Published: Mar 2022
37 citations
37 citations
171 days after retraction
Probióticos – uma espada ou um escudo no desfecho da COVID-19?
Joel Antônio Cordeiro de Abreu, Natália Lopes de Freitas, PEDRO RICARDO G. AZEVEDO et al. (4 authors)
Research Society and Development
Open Access
Published: Mar 2022
152 days after retraction
Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study
John H. Page, Ajit Londhe, Corinne Brooks et al. (34 authors)
BMJ Open
Open Access
Published: Feb 2022
9 citations
9 citations
113 days after retraction
Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients
Ahmet Omma, Abdülsamet Erden, Hakan Apaydın et al. (11 authors)
The Journal of Infection in Developing Countries
Open Access
Published: Jan 2022
3 citations
3 citations
112 days after retraction
Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.
João João Mendes, José Artur Paiva, Filipe Gonzalez et al. (7 authors)
DOAJ (DOAJ: Directory of Open Access Journals)
Published: Jan 2022
1 citation
1 citation
108 days after retraction
An explanatory machine learning framework for studying pandemics: The case of COVID-19 emergency department readmissions
Behrooz Davazdahemami, Hamed M. Zolbanin, Dursun Delen
Decision Support Systems
Open Access
Published: Jan 2022
35 citations
35 citations
99 days after retraction
Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic Review
Daniel Freilich, Jennifer Victory, Anne Gadomski
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2022
2 citations
2 citations
95 days after retraction
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis
Leon Di Stefano, Elizabeth L. Ogburn, Malathi Ram et al. (28 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2022
2 citations
2 citations
92 days after retraction
Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Vinícius Ynoe de Moraes, Alexandre R. Marra, Leandro Luongo de Matos et al. (7 authors)
Einstein (São Paulo)
Open Access
Published: Jan 2022
8 citations
8 citations
82 days after retraction
Organoid technology and lung injury mouse models evaluating effects of hydroxychloroquine on lung epithelial regeneration
Fuxiaonan Zhao, Jianhai Wang, Qi Wang et al. (8 authors)
EXPERIMENTAL ANIMALS
Open Access
Published: Jan 2022
6 citations
6 citations
82 days after retraction
Evolving pharmaceutical therapies for confronting COVID-19: An overview
Roma Ghai, Nagarajan Kandasamy, Tejesvi Mishra et al. (5 authors)
AIP conference proceedings
Open Access
Published: Jan 2022
82 days after retraction
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Megan Crichton, Pieter Goeminne, Krizia Tuand et al. (7 authors)
European Respiratory Review
Open Access
Published: Dec 2021
26 citations
26 citations
65 days after retraction
Paper citing Hydroxychloroquine in the Treatment of COVID-19: A...
Unknown Authors
Unknown Journal
Published: Dec 2021
65 days after retraction
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials
Qinglin Cheng, Gang Zhao, Chen Jun-fang et al. (5 authors)
Journal of Medical Virology
Open Access
Published: Dec 2021
12 citations
12 citations
59 days after retraction
Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
Jiawen Deng, Fangwen Zhou, Kiyan Heybati et al. (11 authors)
Future Virology
Open Access
Published: Dec 2021
26 citations
26 citations
53 days after retraction
ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać et al. (14 authors)
Clinical Microbiology and Infection
Open Access
Published: Nov 2021
145 citations
145 citations
42 days after retraction
Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat et al. (8 authors)
Expert Review of Anti-infective Therapy
Open Access
Published: Oct 2021
5 citations
5 citations
14 days after retraction
Covid-19: Effects of Azithromycin/Hydroxychloroquine/Ivermectin in ambulatory and hospitalized patients
Henry Mejía-Zambrano, Livia Y. Ramos-Calsín
Microbes Infection and Chemotherapy
Open Access
Published: Oct 2021
10 days after retraction
Uso de aminoquinolinas (Cloroquina e Hidroxicloroquina) no tratamento da COVID-19: uma revisão sistemática
Luan Victor Almeida Lima, Filipe Saboya Santos, Nataly Abreu Alves et al. (6 authors)
Research Society and Development
Open Access
Published: Oct 2021
1 citation
1 citation
10 days before retraction
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Chenyang Zhang, Huaqing Jin, Yi Feng Wen et al. (4 authors)
Frontiers in Public Health
Open Access
Published: Sep 2021
38 citations
38 citations
13 days before retraction
Novel Therapeutic Trends in Pneumonia: Antibiotics and Mesenchymal Stem Cells
Zhong Li, Jennifer Ly, Qi Chu
Biomedical Research and Clinical Reviews
Open Access
Published: Sep 2021
14 days before retraction
Clinical manifestation, diagnosis, treatment and prevention of Coronavirus disease-2019 (COVID-19)
Mahendra Pal, Kirubel Paulos Gutama
MOJ Biology and Medicine
Open Access
Published: Sep 2021
2 citations
2 citations
17 days before retraction
Role of Sodium Bicarbonate as Adjuvant Treatment of Nonsevere Computed Tomography-identified COVID-19 Pneumonia: A Preliminary Report
M Elbadrawy, Abdelbaset M. Saleh, Adel El‐Badrawy et al. (7 authors)
Indian Journal of Respiratory Care
Published: Sep 2021
4 citations
4 citations
28 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #39037
Sep 02, 2022Quick Stats
Total Citations:
137
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025